Last updated: 6 March 2024 at 7:45pm EST

Francis Lo Net Worth




The estimated Net Worth of Francis Lo is at least $1.28 Million dollars as of 4 March 2024. Mr. Lo owns over 14,700 units of Adaptive Biotechnologies stock worth over $1,113,941 and over the last 5 years he sold ADPT stock worth over $168,656. In addition, he makes $0 as Chief People Officer at Adaptive Biotechnologies.

Mr. Lo ADPT stock SEC Form 4 insiders trading

Francis has made over 17 trades of the Adaptive Biotechnologies stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 14,700 units of ADPT stock worth $50,421 on 4 March 2024.

The largest trade he's ever made was exercising 25,000 units of Adaptive Biotechnologies stock on 12 October 2020 worth over $195,000. On average, Francis trades about 3,982 units every 71 days since 2020. As of 4 March 2024 he still owns at least 253,745 units of Adaptive Biotechnologies stock.

You can see the complete history of Mr. Lo stock trades at the bottom of the page.





Francis Lo biography

Francis Lo serves as Chief People Officer of the Company. Prior to joining us, from March 2017 to April 2019 Mr. Lo served as Vice President, Human Resources at Whole Foods Market, Inc., a wholly-owned subsidiary of Amazon.com, Inc. that operates natural and organic food supermarkets. From August 2011 to March 2017, Mr. Lo also served in various roles of ascending responsibility with Starbucks Corporation, a public specialty coffee company, including as Director, Global Talent Management from October 2015 to March 2017. Mr. Lo holds an MBA in Business Administration from Stanford University Graduate School of Business and a BA in the Plan II Honors Program (Interdisciplinary Studies with Business Focus) from the University of Texas at Austin.



How old is Francis Lo?

Francis Lo is 39, he's been the Chief People Officer of Adaptive Biotechnologies since 2019. There are 23 older and 1 younger executives at Adaptive Biotechnologies. The oldest executive at Adaptive Biotechnologies Corporation is Peter Neupert, 64, who is the Lead Independent Director.

What's Francis Lo's mailing address?

Francis's mailing address filed with the SEC is C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVENUE EAST, SEATTLE, WA, 98109.

Insiders trading at Adaptive Biotechnologies

Over the last 5 years, insiders at Adaptive Biotechnologies have traded over $685,617,014 worth of Adaptive Biotechnologies stock. The most active insiders traders include Global Investors Lp Viking ..., Global Performance Llc Viki..., and Kevin T Conroy. On average, Adaptive Biotechnologies executives and independent directors trade stock every 6 days with the average trade being worth of $368,167. The most recent stock trade was executed by Stacy L Taylor on 22 August 2024, trading 26,922 units of ADPT stock currently worth $121,149.



What does Adaptive Biotechnologies do?

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery customers. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It also has a research collaboration with Curebase, Inc. to enhance patient participation in clinical studies. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.



What does Adaptive Biotechnologies's logo look like?

Adaptive Biotechnologies Corporation logo

Complete history of Mr. Lo stock trades at Adaptive Biotechnologies

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
4 Mar 2024 Francis Lo
Chief People Officer
Sale 14,700 $3.43 $50,421
4 Mar 2024
253,745
6 Mar 2023 Francis Lo
Chief People Officer
Sale 6,816 $8.57 $58,413
6 Mar 2023
168,469
8 Mar 2022 Francis Lo
Chief People Officer
Sale 3,582 $11.44 $40,978
8 Mar 2022
89,588
4 Mar 2022 Francis Lo
Chief People Officer
Sale 1,569 $12.01 $18,844
4 Mar 2022
93,170
14 May 2021 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
14 May 2021
22,604
15 Apr 2021 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
15 Apr 2021
22,604
15 Mar 2021 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
15 Mar 2021
22,604
16 Feb 2021 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
16 Feb 2021
2,000
15 Jan 2021 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
15 Jan 2021
2,000
15 Dec 2020 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
15 Dec 2020
2,000
16 Nov 2020 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
16 Nov 2020
2,000
15 Oct 2020 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
15 Oct 2020
2,000
12 Oct 2020 Francis Lo
Chief People Officer
Option 25,000 $7.80 $195,000
12 Oct 2020
25,000
15 Sep 2020 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
15 Sep 2020
2,000
17 Aug 2020 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
17 Aug 2020
2,000
15 Jul 2020 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
15 Jul 2020
2,000
18 Jun 2020 Francis Lo
Chief People Officer
Option 2,000 $7.80 $15,600
18 Jun 2020
2,000


Adaptive Biotechnologies executives and stock owners

Adaptive Biotechnologies executives and other stock owners filed with the SEC include: